Indonesia-based Prixa.ai, a healthcare startup, raised USD 3 Million in a funding round. The funding round was led by Trans-Pacific Technology Fund (TPTF) and MDI Ventures. 

This round also witnessed the participation of existing investors which includes Siloam Hospitals Group. 

After this, the total raised amount by the startup is USD 4.5 Million since it was launched in the year 2019. The CEO stated that the funds raised by the company will be utilized to scale the business and increase the customer base. 

Prixa.ai uses a B2B model, it is having a partnership with healthcare payers like different corporations and insurance providers and it serves about 10 million patients.

About the investor – 

MDI Ventures 

MDI ventures started in Jun 2016, by Indra Utoyo and Nicko Widjaja. It is a corporate venture capital firm that is a sub-organization of Telkom Indonesia, it has its own identity and a process of funding. 

Aditia Henri Narendra, MDI Ventures’ general manager of legal and corporate communication, said –  “MDI co-led this financing because Prixa has demonstrated its ability to support insurance companies and hospitals in making medical services more accessible and affordable through its AI telemedicine platform.”

Trans-Pacific Technology Fund

Trans-Pacific Technology fund is a venture capital firm that focuses on investing in tech-based companies. It is based in Taipei, Taiwan and was founded in 2014. It backs the tech companies in their early stages and late stages 

About Prixa.ai

Prixa.ai is a healthcare breakout for patients to payors and providers. It was founded and established by James Roring in June 2019. 

It currently works with four big insurers and has additional insurers in its short-term plan. Prixa.ai also works with Indonesia’s third-largest party administrators, which lets it reach more policyholders.

The platfrom provided by Prixa includes a 24×7 digitally available health assistant to answer the customer’s questions, pharmacy deliveries, telemedicine consultancies, and lab diagnostics.

The user base of the platform rose during the COVID-19 crisis as more customers were trying to find online consultation and solutions for primary care.

“By symptomatically managing patients outside of tertiary care facilities and caring for chronic non-communicable diseases online, Prixa is able to effectively reduce the number of outpatient claims and downstream inpatient cost incurred by healthcare payers, Additionally, the combination of a growing and robust medical database, as well as proven clinical guidelines, contribute to cost efficiency and service optimization through the standardization of treatment by our healthcare providers.” – Rorring said.

We try our best to fact-check and bring the best, well-researched, and non-plagiarized content to you. Please let us know

-if there are any discrepancies in any of our published stories,

-how we can improve,

-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback and thank you for stopping by!

Previous articleCrejo.Fun raises US$3M in seed round
Next articleHolisol raises the debt of USD 3 dollars from Northern Arc

LEAVE A REPLY

Please enter your comment!
Please enter your name here